FANDOM


Vitadyne Labs is an independent pharmaceutical company. In December 3304, Vitadyne Labs announced that it had developed a promising new form nanomedicine which it hoped to bring to market.

Timeline Edit

14 DEC 3304

  • The Interstellar Health Organisation (IHO) has delivered a preliminary report on the nanomedicines recently developed by Vitadyne Labs. The summary stated: "Nanomedicine is a carefully regulated branch of medical science, with little scope for public application, but Vitadyne's nanomeds are more sophisticated and reliable than any existing product. Furthermore, Vitadyne's data regarding healing, disease treatment and extension of longevity has been verified. Having confirmed the product's effectiveness, IHO teams are now conducting independent tests with patients." Media outlet Vox Galactica published this viewpoint from healthcare analyst Dr Himari Grey: "The pharmaceutical industry is astonished that a small company like Vitadyne could produce something so advanced. Professor Katrien Rook's credentials are impeccable, of course, but this is a work of genius. These nanomeds could be the most exciting thing in medicine for decades."[1]

06 DEC 3304

  • Independent company Vitadyne Labs has developed an innovative new form of nanomedicine. Professor Katrien Rook published the following press release: "Nanomeds are sophisticated pharmaceuticals that use nanoscale materials to repair cell damage on a molecular level. They can heal any injury in a fraction of the normal time, and can potentially cure almost any disease and infection. Furthermore, regular use of nanomeds affects cellular senescence, drastically slowing the ageing process. In theory, nanomed users will live between 30 and 50 years longer, and will enjoy near-perfect health during those extra decades. After months of trials we are inviting medical authorities, including the Interstellar Health Organisation, to review our data. Pending approval, we hope to have Vitadyne nanomeds on the market soon.”[2]

References Edit

  1. GalNet: Positive Response to Vitadyne Nanomeds
  2. GalNet: New Nanomedicine Announced